Investor Relations

SEC Filings

Document Details

Form
Filing Date
Feb 04, 2025
Document Date
Jan 31, 2025
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.